Quest Diagnostics

Quest Diagnostics

Preço: 203.06

Empresa e modelo de negócios

Quest Diagnostics is a leading provider of diagnostic information services, primarily focused on laboratory testing and related services. Its core products include clinical laboratory tests, anatomic pathology services, and genetic testing. The company operates through various segments, including Diagnostic Information Services and Diagnostic Solutions, with major revenue sources stemming from patient testing, healthcare provider services, and employer services. Quest Diagnostics serves a diverse clientele, including hospitals, physicians, and patients.

Perfil de investimento

The investment profile of Quest Diagnostics is more aligned with dividend investors due to its consistent dividend yield of 2.0%. The company demonstrates stable revenue streams, although recent quarterly revenue showed a slight decline. This stability may appeal to those seeking income rather than aggressive growth. The stock may also attract value investors looking for established companies with reliable earnings.

Site oficial

Métricas fundamentais (experimental)

EPS (TTM) — lucro por ação dos últimos 12 meses, $
9.17 OK
Receita QoQ — crescimento da receita trimestre contra trimestre
3.2%
Surpresa de EPS
3.0% em linha
Volatilidade 20d
1.3% estável
Dividend yield
2.0% moderado última data ex-dividendo: 2026-04-06
Dados FMP / FinFeed atualizados: 2026-06-13
Rec.: Comprar Potencial: 71 Risco: 36 Atualizado: 2026-06-13 02:56
Como a recomendação funciona
Por que a IA pensa assim:
Strong fundamentals and positive momentum support growth potential.

Acompanhar no portfólio

Gráfico de preço

Recomendação da IA Previsão do analista Evento de calendário Sinal positivo Sinal negativo Neutro / atualização Manter / informativo B My buy S My sell
Mudanças na recomendação da IA
Data Antes Depois Motivo
2026-05-30 02:36 Manter Comprar Stable earnings but mixed momentum signals present uncertainty.
2026-05-08 15:18 Manter Weak momentum and fundamentals suggest caution.
2026-05-07 03:06 Manter Comprar Компания показывает стабильные финансовые показатели, однако недавнее снижение цен акций и отрицательная динамика выручки могут указывать на неопределенность в краткосрочной перспективе.
Previsões de analistas
Data Analista Action Alvo Preço na época
2026-04-21 18:51 Evercore ISI Preço-alvo elevado 210 → 225 205.18
2026-04-21 18:00 Jefferies Preço-alvo elevado 220 → 225 205.18
2026-04-08 13:09 Evercore ISI Atualizar — → 210 198.81

Nada ainda